ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DLMAF

Go back to ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

ANI Pharma (ANIP) Misses Q2 EPS by 6c

August 8, 2022 6:52 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $73.9 million versus the consensus estimate of $71.13 million.

GUIDANCE:

ANI Pharma sees FY2022 EPS of $1.34-$1.62, versus the consensus... More